The properties of myosin modified at the SH2 group (Cys-697) were studied a
nd compared with the previously reported properties of myosin modified at t
he SH1 group (Cys-707). 4-[N-[(iodoacetoxy)ethyl]-N methylamino]-7-nitroben
z-2-oxa-1,3-diazole (IANBD) was used for selective modification of the SH2
group on myosin. SH2-labeled heavy meromyosin (SH2-HMM), similar to SH1-lab
eled HMM (SH1-HMM), did not propel actin filaments in the in vitro motility
assays. SH1- and SH2-HMM produced similar amounts of load in the mixtures
with unmodified HMM; the sliding speed of actin filaments gradually decreas
ed with an increase in the fraction of either one of the modified HMMs in t
he mixture. In analogy to SH1-labeled myosin subfragment 1 (SH1-S1), SH2-la
beled S1 (SH2-S1) activated regulated actin in the in vitro motility assays
. SH2 modification inhibited Mg-ATPase of S1 and its activation by actin. T
he weak binding of S1 to actin was unaffected whereas the strong binding wa
s weakened by SH2 modification. Overall, our results demonstrate similar be
havior of SH1- and SH2-modified myosin heads in the in vitro motility assay
s despite some differences in their enzymatic properties. The effects of th
ese modifications are ascribed to the location of the SH1-SH2 helix relativ
e to other functional centers of S1.